NDC Package 49281-590-05 Menquadfi

Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49281-590-05
Package Description:
5 VIAL, SINGLE-DOSE in 1 CARTON / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)
Product Code:
Proprietary Name:
Menquadfi
Non-Proprietary Name:
Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, And Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen
Substance Name:
Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen; Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen; Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen; Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen
Usage Information:
MenQuadfi™ is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. MenQuadfi is indicated for use in individuals 2 years of age and older.MenQuadfi does not prevent N. meningitidis serogroup B disease.
11-Digit NDC Billing Format:
49281059005
NDC to RxNorm Crosswalk:
  • RxCUI: 2360583 - meningococcal (groups A, C, Y and W-135) polysaccharide tetanus toxoid conjugate vaccine 0.5 ML Injection
  • RxCUI: 2360583 - 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection
  • RxCUI: 2360588 - MenQuadfi vaccine 0.5 ML Injection
  • RxCUI: 2360588 - 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection [Menquadfi]
  • RxCUI: 2360588 - MenQuadfi Meningococcal (Groups A,C,Y and W-135) Polysaccharide Tetanus Toxoid Conjugate Vaccine 0.5 ML Injection
  • Product Type:
    Vaccine
    Labeler Name:
    Sanofi Pasteur Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Sample Package:
    No
    FDA Application Number:
    BLA125701
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    06-30-2023
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    49281-590-011 VIAL, SINGLE-DOSE in 1 CARTON / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)
    49281-590-1010 VIAL, SINGLE-DOSE in 1 CARTON / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49281-590-05?

    The NDC Packaged Code 49281-590-05 is assigned to a package of 5 vial, single-dose in 1 carton / .5 ml in 1 vial, single-dose (49281-590-58) of Menquadfi, a vaccine label labeled by Sanofi Pasteur Inc.. The product's dosage form is injection, solution and is administered via intramuscular form.

    Is NDC 49281-590 included in the NDC Directory?

    Yes, Menquadfi with product code 49281-590 is active and included in the NDC Directory. The product was first marketed by Sanofi Pasteur Inc. on June 30, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 49281-590-05?

    The 11-digit format is 49281059005. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249281-590-055-4-249281-0590-05